Activation and Monitoring of mtDNA Damage in Cancer Cells via the “Proton-Triggered” Decomposition of an Ultrathin Nanosheet

• Published in: ACS applied materials & interfaces 2021-01, Vol.13 (3), p.3669-3678
• Main Authors: Liu, Jun W, Yang, Yong G, Wang, Kui, Wang, Ge, Shen, Cong C, Chen, Yue H, Liu, Yu F, James, Tony D, Jiang, Kai, Zhang, Hua
• Format: Article
• Language: English
• Subjects: Biological and Medical Applications of Materials and Interfaces; Biosensing Techniques - methods; Calcium - chemistry; Cell Line; DNA Damage - drug effects; DNA, Mitochondrial - genetics; Durapatite - chemistry; Durapatite - pharmacology; Hep G2 Cells; Humans; Nanostructures - chemistry; Protons
• ISSN: 1944-8244; 1944-8252
• DOI: 10.1021/acsami.0c20060

Mitochondrial DNA (mtDNA) damage is a very important molecular event, which has significant effects on living organisms. Therefore, a particularly important challenge for biomaterials research is to develop functionalized nanoparticles that can activate and monitor mtDNA damage and instigate cancer cell apoptosis, and as such eliminate the negative effects on living organisms. Toward that goal, with this research, we have developed a hydroxyapatite ultrathin nanosheet (HAP-PDCns)a high Ca2+ content biomaterial. HAP-PDCns undergoes proton-triggered decomposition after entering cancer cells via clathrin-mediated endocytosis, and then, it selectively concentrates in the charged mitochondrial membrane. This kind of proton-triggered decomposition phenomenon facilitates mtDNA damage by causing instantaneous local calcium overload in the mitochondria of cancer cells, and inhibits tumor growth. Importantly, at the same time, a real-time green-red-green fluorescence change occurs that correlates with the degree of mtDNA deterioration because of the changes in the highest occupied molecular orbital–lowest unoccupied molecular orbital energy gaps during this process. Significantly, the decomposition and the fluorescence changes cannot be triggered in normal cells. Thus, HAP-PDCns can selectively induce apoptosis and the death of a cancer cell by facilitating mtDNA damage, but does not affect normal cells. In addition, HAP-PDCns can simultaneously monitor the degree of mtDNA damage. We anticipate that this design strategy can be generalized to develop other functionalized biomaterials that can be used to instigate the positive effects of mtDNA damage on living organisms while eliminating any negative effects.